A 65-year-old man developed granulomatosis with polyangiitis (GPA), a type of anti-neutrophilic cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), after receiving a stem cell transplant for another autoimmune condition, according to a case report. “[Our] case report suggests that [AAV] may develop in the setting of stem cell transplantation and must…
Man Develops AAV Following Blood Stem Cell Transplant: Case Study
People with eosinophilic granulomatosis with polyangiitis (EGPA) are more likely to report a greater range of symptoms than their doctors, a study that drew on patient- and physician-reported databases found, while showing similarities on other points, like relapse frequency. Given the importance of the patient perspective in both research and…
A man with granulomatosis with polyangiitis — a type of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) — and abnormally raised urine protein levels, a sign of kidney disease, has been described in a recent case report. Notably, urine protein levels usually are not significantly elevated in people with granulomatosis…
A subtype of antibody-producing B-cells was significantly higher in the bloodstream of ANCA-associated vasculitis (AAV) patients with active kidney involvement compared with those who were in remission and healthy individuals. These findings may help monitor disease progression, as well as provide insights into AAV development, the researchers noted. The…
Summer promises good weather, high spirits, and easy travel. There’s nothing like an old-fashioned road trip to capture the excitement and freedom of exploration. Though there might be a thunderstorm here and there, it’s tempting to get on the road and stay there till fall. For those of us with…
Many ANCA-associated vasculitis (AAV) patients with skin lesions test negative for ANCA antibodies — proteins produced by the immune system that bind to white blood cells called neutrophils, ultimately triggering an autoimmune reaction. As a result, researchers contend that ANCA testing should not be used as the only criteria…
One evening last week, I reluctantly agreed to meet a friend at a dance studio. I had no intention of joining in. Me — a salsa dancer? Don’t be ridiculous! I’m a former soccer player with minimal dancing experience who often trips down the stairs. Confident that I could enter…
Tavneos (avacopan) reduced respiratory, ear, nose, and throat (ENT) involvement among people with ANCA-associated vasculitis (AAV), but did not significantly outperform prednisone in its ability to do so, according to a substudy of the larger Phase 3 ADVOCATE trial. The treatment also significantly lowered patients’ reliance on glucocorticoid…
People with a past history of autoimmune disease before developing ANCA-associated vasculitis (AAV) have significantly fewer relapses after achieving remission, a study reported. Post-remission chances of a relapse were 67% lower in these AAV patients and took longer to occur, findings showed. Its researchers argued that these results support a…
Exercise is an interesting topic in the world of autoimmune diseases. What type should we do? How much of it do we need? Are there specific concerns regarding cardio or other strenuous activities? After several years of living with vasculitis, I’ve found the answers aren’t all that complicated. If…
Recent Posts
- Study ties specific immune pathway to kidney damage in AAV
- Plasma exchange therapy may boost short-term survival in AAV
- When talking with patients, we should use language that creates connection
- Kidney tissue patterns may influence treatment response in AAV
- Chronic lung condition doubles infection risk in AAV patients: Study